Christopher Paige
Director/Board Member at AVROBIO, INC.
Net worth: 299 227 $ as of 2024-04-29
Profile
Dr. Christopher Paige is an Independent Director at Avrobio, Inc. and a Professor at University of Toronto.
He is on the Board of Directors at Avrobio, Inc. and Centre For Commercialization of Regenerative Medicine.
Dr. Paige was previously employed as a Vice President-Research by University Health Network, a Director-Research by Wellesley Hospital, and a Member by Basel Institute for Immunology.
He also served on the board at Arthritis Research Foundation and Ontario Institute for Cancer Research.
He received his undergraduate degree from the University of Notre Dame and a doctorate degree from Cornell University Graduate School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
AVROBIO INC
0.56% | 2024-03-06 | 252,512 ( 0.56% ) | 299 227 $ | 2024-04-29 |
Christopher Paige active positions
| Companies | Position | Start |
|---|---|---|
| AVROBIO, INC. | Director/Board Member | 2015-12-31 |
Centre For Commercialization of Regenerative Medicine
 Centre For Commercialization of Regenerative Medicine BiotechnologyHealth Technology Centre For Commercialization of Regenerative Medicine supports our partners to develop and commercialize cell and gene therapies and regenerative medicine technologies. Its services include business, technical and facilities. The company is headquartered in Toronto, Canada. | Director/Board Member | - |
| University of Toronto | Corporate Officer/Principal | 1986-12-31 |
Former positions of Christopher Paige
| Companies | Position | End |
|---|---|---|
University Health Network
 University Health Network Hospital/Nursing ManagementHealth Services University Health Network operates as a healthcare and medical research organization that provides patient care, education, and research services. Its programs include arthritis program, joint department of medical imaging, Krembil neuroscience center, laboratory medicine program, medical and community care, multi-organ transplant, Peter Munk cardiac center, Princess Margaret cancer, surgery and critical care program, and Toronto rehab. The company was founded in 1986 and is headquartered in Toronto, Canada. | Chief Tech/Sci/R&D Officer | 2016-09-30 |
| Basel Institute for Immunology | Corporate Officer/Principal | 1986-12-31 |
| Arthritis Research Foundation | Director/Board Member | - |
| Wellesley Hospital | Chief Tech/Sci/R&D Officer | - |
Ontario Institute for Cancer Research
 Ontario Institute for Cancer Research Hospital/Nursing ManagementHealth Services Ontario Institute for Cancer Research provides research on the prevention, early detection, diagnosis, and treatment of cancer. It offers Innovation programs, like cancer stem cell, innovation in target validation, and smarter imaging, Technology programs, like drug discovery, genome technologies, informatics and bio-computing, imaging translation, and tranformative pathology, and Translation programs. The company was founded by Calvin R. Stiller in December 2005 and is headquartered in Toronto, Canada. | Director/Board Member | - |
Training of Christopher Paige
| University of Notre Dame | Undergraduate Degree |
| Cornell University Graduate School | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| AVROBIO, INC. | Health Technology |
| Private companies | 5 |
|---|---|
Ontario Institute for Cancer Research
Ontario Institute for Cancer Research Hospital/Nursing ManagementHealth Services Ontario Institute for Cancer Research provides research on the prevention, early detection, diagnosis, and treatment of cancer. It offers Innovation programs, like cancer stem cell, innovation in target validation, and smarter imaging, Technology programs, like drug discovery, genome technologies, informatics and bio-computing, imaging translation, and tranformative pathology, and Translation programs. The company was founded by Calvin R. Stiller in December 2005 and is headquartered in Toronto, Canada. | Health Services |
Centre For Commercialization of Regenerative Medicine
Centre For Commercialization of Regenerative Medicine BiotechnologyHealth Technology Centre For Commercialization of Regenerative Medicine supports our partners to develop and commercialize cell and gene therapies and regenerative medicine technologies. Its services include business, technical and facilities. The company is headquartered in Toronto, Canada. | Health Technology |
University Health Network
University Health Network Hospital/Nursing ManagementHealth Services University Health Network operates as a healthcare and medical research organization that provides patient care, education, and research services. Its programs include arthritis program, joint department of medical imaging, Krembil neuroscience center, laboratory medicine program, medical and community care, multi-organ transplant, Peter Munk cardiac center, Princess Margaret cancer, surgery and critical care program, and Toronto rehab. The company was founded in 1986 and is headquartered in Toronto, Canada. | Health Services |
| Wellesley Hospital | |
| Arthritis Research Foundation |
- Stock Market
- Insiders
- Christopher Paige
